Indications
Agitated or violent behavior (an option for high violence risk). Moderate to severe pain.
Contraindications
Hypersensitivity. Relative or controversial: head trauma, intracranial mass or hemorrhage, hypertension, angina, stroke, underlying psychiatric disorder.
Adult dose
Pain: 0.25 mg/kg IM, IV or IO (max initial dose 25 mg; max cumulative dose 100 mg). May repeat after 5 min if pain and vital signs allow.
Agitation: 2 mg/kg IV (onset 1 min) or 4 mg/kg IM (onset 3-5 min)
Induction, as for RSI (FDA label): 1-4.5 mg/kg IV over 60 seconds; 2 mg/kg is the average and gives 5-10 minutes of anesthesia. IM: 6.5-13 mg/kg. Pushing it fast can cause respiratory depression and a rise in BP.
Pediatric dose
Pain: 0.25 mg/kg IM, IV or IO (max initial dose 25 mg; max cumulative dose 100 mg). May repeat after 5 min if pain and vital signs allow.
Agitation: 1 mg/kg IV or 3 mg/kg IM
Induction (FDA label): no pediatric dose. Safety and effectiveness below age 16 have not been established.
Route
IV, IM, IO
Special considerations
Watch closely for hypoventilation and oversedation, and use capnography if it's available. Get the patient on a cardiac monitor as soon as you can after sedation. It should be considered for delirium with agitated behavior, as in stimulant overdose. An overdose can cause panic and aggressive behavior, and rarely seizures, raised ICP and cardiac arrest.
Follow your local protocols. Sources: National Model EMS Clinical Guidelines (NASEMSO, 2022): Pain Management; Agitated or Violent Patient/Behavioral Emergency; Stimulant Poisoning/Overdose. FDA drug labels: Ketalar. Levels from the National EMS Scope of Practice Model (2019).